Position in PFE
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$283,204
-$44,630 QoQ
Shares Held
11,761
+0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#2,169
of 2,821 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GENESIS PRIVATE WEALTH, LLC holds $3,623,905 across 9 Drug Manufacturers - General names. PFE ranks #8 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
585 | $701,666 | |
| 2 | ABBV |
AbbVie Inc.
|
2,224 | $559,647 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
3,364 | $425,007 | |
| 4 | JNJ |
Johnson & Johnson
|
1,629 | $413,717 | |
| 5 | AMGN |
Amgen Inc
|
1,042 | $377,329 | |
| 6 | SNY |
Sanofi
|
7,644 | $326,093 | |
| 7 | AZN |
Astrazeneca PLC
|
1,524 | $288,980 | |
| 8 | PFE |
Pfizer Inc
This page
|
11,761 | $283,204 |
All Filings in PFE
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $283,204 | 11,761 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $327,834 | 11,675 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $253,731 | 10,190 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $261,119 | 10,248 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $364,836 | 15,051 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $382,228 | 15,084 | Shares | Sole | 2025-04-23 | |
| No filing history on record for this holder in this stock. | ||||||